These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33834062)

  • 1. Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application.
    Furuyama N; Sircili MP
    Biomed Res Int; 2021; 2021():1490732. PubMed ID: 33834062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gram-negative outer membrane vesicles in vaccine development.
    Collins BS
    Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review].
    Yi J; Liu Q; Kong Q
    Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.
    Zhu Z; Antenucci F; Villumsen KR; Bojesen AM
    mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling of Gram-negative bacterial outer membrane vesicles: Current perspectives.
    Lee J; Kim OY; Gho YS
    Proteomics Clin Appl; 2016 Oct; 10(9-10):897-909. PubMed ID: 27480505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OMV Vaccines and the Role of TLR Agonists in Immune Response.
    Mancini F; Rossi O; Necchi F; Micoli F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions.
    Schwechheimer C; Kuehn MJ
    Nat Rev Microbiol; 2015 Oct; 13(10):605-19. PubMed ID: 26373371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial outer membrane vesicles, a potential vaccine candidate in interactions with host cells based.
    Cai W; Kesavan DK; Wan J; Abdelaziz MH; Su Z; Xu H
    Diagn Pathol; 2018 Dec; 13(1):95. PubMed ID: 30537996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria.
    Kulkarni HM; Jagannadham MV
    Microbiology (Reading); 2014 Oct; 160(Pt 10):2109-2121. PubMed ID: 25069453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine Development.
    Valguarnera E; Feldman MF
    Methods Enzymol; 2017; 597():285-310. PubMed ID: 28935107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial outer membrane vesicles as a platform for biomedical applications: An update.
    Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y
    J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
    Huang W; Meng L; Chen Y; Dong Z; Peng Q
    Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gram-negative outer membrane: structure, biochemistry and vaccine potential.
    Owen P
    Biochem Soc Trans; 1992 Feb; 20(1):1-6. PubMed ID: 1633932
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteomics in gram-negative bacterial outer membrane vesicles.
    Lee EY; Choi DS; Kim KP; Gho YS
    Mass Spectrom Rev; 2008; 27(6):535-55. PubMed ID: 18421767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with outer membrane vesicles and the fimbrial protein FlfA offers improved protection against lesions following challenge with Gallibacterium anatis.
    Persson G; Pors SE; Thøfner ICN; Bojesen AM
    Vet Microbiol; 2018 Apr; 217():104-111. PubMed ID: 29615242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioengineering bacterial outer membrane vesicles as vaccine platform.
    Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
    Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis Mediated by Bacterial Membrane Vesicles.
    Gilmore WJ; Bitto NJ; Kaparakis-Liaskos M
    Subcell Biochem; 2021; 97():101-150. PubMed ID: 33779916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.
    Roier S; Blume T; Klug L; Wagner GE; Elhenawy W; Zangger K; Prassl R; Reidl J; Daum G; Feldman MF; Schild S
    Int J Med Microbiol; 2015 May; 305(3):298-309. PubMed ID: 25592265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.